Sep 13, 2017 11:00 am UTC| Business
HAIFA, Israel, Sept. 13, 2017 -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the company has been issued two new patents by...
Sep 13, 2017 11:00 am UTC| Business
MILAN, Italy, Sept. 13, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, announced today positive results from the company’s Phase 2b randomized, double-blind, placebo-controlled study...
Sep 13, 2017 11:00 am UTC| Business
EDINBURGH, United Kingdom, Sept. 13, 2017 -- NuCana plc announced the presentation of interim first-in-human data from a Phase 1 clinical study of NUC-3373, its ProTide transformation of the active anti-cancer...
Sep 13, 2017 11:00 am UTC| Business
Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and...
Sep 13, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 13, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop...
ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 13, 2017 11:00 am UTC| Business
YONKERS, N.Y., Sept. 13, 2017 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant...
Sep 13, 2017 11:00 am UTC| Business
HOLLYWOOD, Fla., Sept. 13, 2017 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, announced today that it was selected by the New...
The “Takaichi Trade”: How Japan’s First Female PM Is Shaping the Yen
How the US–India tariff truce boosts major Indian industries, Surat to Pharma